Buprenorphine Pharmacology Related to Addiction Treatment - 21

Phase 2

Completed

• Conditions: Opioid-Related Disorders

• Registration Number: NCT00000239
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to examine if chronic buprenorphine administration will generate supersensitivity to opiates.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Status Verified: 2002-12
• Last Update Submitted: 2005-08-16
• Last Update Posted: 2005-08-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Drug use
Opioid agonist effects
Opiate withdrawal
Physiological changes in: pupil diameter, blood pressure, heart rate, respiration

Trial Locations

Locations (1)

Treatment Research Center; 🇺🇸 Burlington, Vermont, United States